Article
Association of the Complement Factor H Y402H Polymorphism and Response to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration: An Updated Meta-Analysis.
Ophthalmic research - 1 Jan 2024
Roshanshad Amirhossein, Moosavi Seyed Ali, Arevalo J Fernando
Abstract excerpt
INTRODUCTION: Anti-vascular endothelial growth factor (anti-VEGF) agents have a variable effect on patients with age-related macular degeneration (AMD) that has been attributed to several causes, including genetic factors. We evaluated the effects of Complement Factor H (CFH) rs1061170/Y402H polymorphism on the response to anti-VEGF therapy among AMD patients. METHODS: PubMed, Scopus, EMBASE, Web of Science, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.